1. Home
  2. OSIS vs NEO Comparison

OSIS vs NEO Comparison

Compare OSIS & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • NEO
  • Stock Information
  • Founded
  • OSIS 1987
  • NEO 2001
  • Country
  • OSIS United States
  • NEO United States
  • Employees
  • OSIS N/A
  • NEO N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • NEO Precision Instruments
  • Sector
  • OSIS Technology
  • NEO Health Care
  • Exchange
  • OSIS Nasdaq
  • NEO Nasdaq
  • Market Cap
  • OSIS 2.4B
  • NEO 2.1B
  • IPO Year
  • OSIS 1997
  • NEO 1999
  • Fundamental
  • Price
  • OSIS $150.70
  • NEO $15.04
  • Analyst Decision
  • OSIS Strong Buy
  • NEO Strong Buy
  • Analyst Count
  • OSIS 5
  • NEO 9
  • Target Price
  • OSIS $173.00
  • NEO $19.89
  • AVG Volume (30 Days)
  • OSIS 202.8K
  • NEO 792.3K
  • Earning Date
  • OSIS 10-24-2024
  • NEO 11-05-2024
  • Dividend Yield
  • OSIS N/A
  • NEO N/A
  • EPS Growth
  • OSIS 41.23
  • NEO N/A
  • EPS
  • OSIS 7.68
  • NEO N/A
  • Revenue
  • OSIS $1,603,555,000.00
  • NEO $644,118,000.00
  • Revenue This Year
  • OSIS $11.52
  • NEO $12.93
  • Revenue Next Year
  • OSIS $4.72
  • NEO $9.70
  • P/E Ratio
  • OSIS $19.61
  • NEO N/A
  • Revenue Growth
  • OSIS 24.35
  • NEO 12.06
  • 52 Week Low
  • OSIS $116.38
  • NEO $12.77
  • 52 Week High
  • OSIS $158.69
  • NEO $21.22
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 59.86
  • NEO 52.58
  • Support Level
  • OSIS $131.34
  • NEO $13.35
  • Resistance Level
  • OSIS $156.06
  • NEO $16.60
  • Average True Range (ATR)
  • OSIS 3.83
  • NEO 0.67
  • MACD
  • OSIS 1.71
  • NEO 0.18
  • Stochastic Oscillator
  • OSIS 79.39
  • NEO 53.98

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

Share on Social Networks: